Genetics of Neurodegenerative Disease: Neurochip and Beyond

                      Workshop     Participant List     Executive Summary

AGENDA
Day 1

9:00 a.m.

Welcome and Introduction of Workshop Goals

John Hardy

9:10 a.m.

NeuroGenetics Research Consortium (NGRC) Nat Genet. 2010, 42(9):781-5.

Haydeh Payami

9:30 a.m.

PD GWAS in Dutch Cohort Eur J Hum Genet. 2011 (epub).

Peter Heutink

9:50 a.m.

PD GWAS in Asian Cohort Nat Genet. 2009, 41(12):1303-7. Neurology. 2010, 75(6):508-12.

Wataru Satake

10:10 a.m.	UK PD Consortium, Welcome Trust Case Control Consortium Hum Mol Genet. 2011, 20(2):345-53.	Nick Woods (John Hardy)
10:30 a.m.	BREAK

11:00 a.m.

PD GWAS in French Cohort Hum Mol Genet. 2011, Feb 1;20(3):615-27. Epub 2010 Nov 17.

Maria Martinez

11:20 a.m.

23andMe PD Genetic Analysis

Chuong Do

11:40 a.m.

PD Gene Database www.pdgene.org

Lars Bertram

12:00 p.m.

LUNCH

1:00 p.m.

International PD Genomics Consortium Lancet. 2011, 377(9766):641-49.

Andy Singleton

1:30 p.m.

USA PD GWAS Consortium

Tatiana Foroud

2:00 p.m.

Mega Meta Analysis of PD and Control Datasets―Next Steps

John Hardy and Gerard Schellenberg

3:00 p.m.

BREAK (All participants are welcome to join the meeting.)

3:30 p.m.

Plan and Timeline for Moving Forward

John Hardy, Margaret Sutherland

4:00 p.m.

Phenotype-Genotype Integrator (PheGenI) www.genome.gov/27543987

Lucia Hindorff

4:15 p.m.

Genetic Architecture of Disease

Henry Houlden

4:45 p.m.

Consensus Disease Pathways

Jeff Vance

5:15 p.m.

End of Day 1

6:30‒8:30 p.m.

RECEPTION (all participants)

Lessons Learned From Immunochip and Cardio-Metabochip

Illumina Sarah Neugebauer

Neurochip Design: Leverage Validated Content and Flexible Array Formats

Affymetrix Andrea Finn

Day 2

9:00 a.m.

Introduction to the NeuroChip Initiative

John Hardy

9:20 a.m.

Summary of AD GWAS

Julie Williams, Gerard Schellenberg, Philippe Amouyel, Lindsay Farrer, Ekaterina Rogaeva

10:20 a.m.

Summary of PSP GWA Studies

Gerard Schellenberg

10:40 a.m.

BREAK

11:00 a.m.

Summary of Stroke GWA Studies

Michael Nalls

11:20 a.m.

Summary of MSA GWA Studies

Henry Houlden

11:40 a.m.

Summary of FTD GWA Studies

Vivianna Van Deerlin

12:10 p.m.

LUNCH

1:10 p.m.

Summary of PD GWA Studies

Andy Singleton, Tatiana Foroud

1:50 p.m.

Summary of ALS GWA Studies

Bob Brown, Bryan Traynor, Leonard van den Berg, Ammar Al Chalabi

2:20 p.m.

Summary of MS GWA Studies

Peggy Pericak-Vance

2:50 p.m.

BREAK

3:10 p.m.

NeuroChip Discussion―Criteria, Development, and Implementation

John Hardy

3:50 p.m.

Inclusion of Known Mutations, SNPs for Drug Toxicities

Marc Cruts

4:10 p.m.

Next Steps―Timeline for Development and Implementation

John Hardy, Margaret Sutherland

5:00 p.m.

End of Meeting